Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin C Pritchard

Showing results (51-60 of 172) with videos related to

Pageof 18
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 6, 2016
CADD score has limited clinical validity for the identification of pathogenic variants in noncoding regions in a hereditary cancer panelCheryl A Mather, Sean D Mooney, Stephen J Salipante, et al.
Clinical Chemistry|April 11, 2018
Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput SequencingAdam Waalkes, Nahum Smith, Kelsi Penewit, et al.
Human Pathology|May 4, 2018
Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndromeJessica A Hemminger, Rachel Pearlman, Sigurdis Haraldsdottir, et al.
JNCI Cancer Spectrum|November 23, 2020
Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at StanfordAser Abrha, Navika D Shukla, Rachel Hodan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2020
Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots"Jennifer N Dines, Brian H Shirts, Thomas P Slavin, et al.
JCO Precision Oncology|September 14, 2020
Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell CarcinomaAngela Steineck, Niklas Krumm, Jay F Sarthy, et al.
JCO Precision Oncology|July 14, 2022
<i>BRCA2</i> Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case SeriesLynn Symonds, Erik Konnick, Funda Vakar-Lopez, et al.
American Journal of Clinical Pathology|April 29, 2016
Applying Ancestry and Sex Computation as a Quality Control Tool in Targeted Next-Generation SequencingPatrick C Mathias, Emily H Turner, Sheena M Scroggins, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 14, 2011
Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studiesColin C Pritchard, Evan Kroh, Brent Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
CH Mutations in 16,812 Advanced Cancer Patients-LetterEmmanuel S Antonarakis, Katherine L Nathanson, Kim A Reiss, et al.
Pageof 18

Showing results (51-60 of 172) with videos related to

Sort By:
Pageof 18
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 6, 2016
CADD score has limited clinical validity for the identification of pathogenic variants in noncoding regions in a hereditary cancer panelCheryl A Mather, Sean D Mooney, Stephen J Salipante, et al.
Clinical Chemistry|April 11, 2018
Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput SequencingAdam Waalkes, Nahum Smith, Kelsi Penewit, et al.
Human Pathology|May 4, 2018
Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndromeJessica A Hemminger, Rachel Pearlman, Sigurdis Haraldsdottir, et al.
JNCI Cancer Spectrum|November 23, 2020
Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at StanfordAser Abrha, Navika D Shukla, Rachel Hodan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2020
Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots"Jennifer N Dines, Brian H Shirts, Thomas P Slavin, et al.
JCO Precision Oncology|September 14, 2020
Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell CarcinomaAngela Steineck, Niklas Krumm, Jay F Sarthy, et al.
JCO Precision Oncology|July 14, 2022
<i>BRCA2</i> Alterations in Neuroendocrine/Small-Cell Carcinoma Prostate Cancer: A Case SeriesLynn Symonds, Erik Konnick, Funda Vakar-Lopez, et al.
American Journal of Clinical Pathology|April 29, 2016
Applying Ancestry and Sex Computation as a Quality Control Tool in Targeted Next-Generation SequencingPatrick C Mathias, Emily H Turner, Sheena M Scroggins, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 14, 2011
Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studiesColin C Pritchard, Evan Kroh, Brent Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2025
CH Mutations in 16,812 Advanced Cancer Patients-LetterEmmanuel S Antonarakis, Katherine L Nathanson, Kim A Reiss, et al.
Pageof 18